AlphaFold changed how scientists predict protein structures and how non-specialist readers understand computational biology. The public claim often jumps from structure prediction to cures, but drug discovery also needs binding studies, cell work, animal data, toxicity checks, clinical endpoints and manufacturing reality.
Our coverage treats AI biology as a system: model training, benchmark performance, wet-lab confirmation, reproducibility, data access and the incentives of biotech companies. The strongest stories are not the loudest product demos; they are the ones where computation and experiment meet.
What readers should watch
The important signal is not whether a story sounds futuristic. It is whether the evidence is specific, reproducible and connected to a method readers can inspect. Science Report follows the paper trail and the institutional record before writing the public explanation.
Source notes
Model papers, protein databases, laboratory validation, clinical-trial records, company disclosures and independent structural-biology analysis.
Updated May 4, 2026: source-note structure and topic links reviewed by the editorial desk